Cell Surface Bio was founded by scientists for scientists to provide extensively validated recombinant antibodies with unparalleled specificity so that you can have absolute confidence in your data. Cell Surface Bio’s antibodies are developed using our VeRSaMAb technology, where antibodies are rigorously validated for common applications, recombinant for engineered enhancements, and specific for binding only your target. Our mission is to provide scientists only the highest quality antibodies, because as fellow scientists, we know that your time in the lab is valuable.
VeRSaMAbs are generated using 20 years of antibody discovery and characterization technologies (Read our Story).
- All CSB antibodies are extensively validated for widely used applications, including flow cytometry and immunofluorescence-immunocytochemistry
- All CSB antibodies are recombinantly engineered to improve detection, reduce background binding, minimize batch-to-batch variability, and enable experimental consistency
- All CSB antibodies are tested for unparalleled specificity against the entire 6,000 human membrane proteome using the Membrane Proteome Array